Axon Enterprise (AXON) Financials

Annual Income Statements for Axon Enterprise

This table shows Axon Enterprise's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	20	17	5.21	546	0.88	-1.72	-60	147	176	377
Consolidated Net Income / (Loss)	20	17	5.21	29	0.88	-1.72	-60	147	176	377
Net Income / (Loss) Continuing Operations	20	17	5.21	546	0.88	-1.72	-60	147	176	377
Total Pre-Tax Income	35	31	16	28	2.07	-6.29	-141	196	157	382
Total Operating Income	35	32	13	25	-6.39	-14	-168	93	157	59
Total Gross Profit	129	171	207	517	307	416	541	726	955	1,241
Total Revenue	198	268	344	840	531	681	863	1,187	1,561	2,083
Operating Revenue	198	268	344	840	531	681	863	1,187	1,561	2,083
Total Cost of Revenue	69	98	137	323	224	265	322	461	605	841
Operating Cost of Revenue	69	98	137	323	224	265	322	461	605	841
Total Operating Expenses	93	139	194	-25	314	430	709	633	799	1,183
Selling, General & Admin Expense	70	108	139	157	213	307	515	399	495	741
Research & Development Expense	24	31	55	77	101	123	194	234	304	442
Total Other Income / (Expense), net	0.03	-0.35	2.74	3.26	8.46	7.86	27	103	0.21	323
Interest & Investment Income	0.03	-0.35	2.74	3.26	8.46	7.86	1.48	4.29	42	37
Other Income / (Expense), net	-	-	-	-	-	-	25	99	-42	286
Income Tax Expense	15	14	11	-1.10	1.19	-4.57	-81	49	-19	4.47
Basic Earnings per Share	$0.37	$0.33	$0.10	$0.52	$0.01	($0.03)	($0.91)	$2.07	$2.37	$4.98
Weighted Average Basic Shares Outstanding	53.55M	52.67M	52.73M	56.39M	59.19M	61.78M	66.19M	71.09M	74.20M	75.75M
Diluted Earnings per Share	$0.36	$0.32	$0.10	$0.50	$0.01	($0.03)	($0.91)	$2.03	$2.33	$4.80
Weighted Average Diluted Shares Outstanding	54.64M	53.54M	53.90M	57.92M	60.02M	61.78M	66.19M	72.53M	75.46M	78.56M
Weighted Average Basic & Diluted Shares Outstanding	53.90M	52.40M	52.10M	58.83M	59.53M	63.78M	70.93M	72.86M	75.30M	76.62M

This table shows Axon Enterprise's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	12	29	45	12	61	57	133	41	67	136
Consolidated Net Income / (Loss)	12	29	45	12	61	57	133	41	67	136
Net Income / (Loss) Continuing Operations	12	29	45	12	61	57	133	41	67	136
Total Pre-Tax Income	21	34	42	-12	72	56	166	51	80	86
Total Operating Income	32	22	17	40	57	43	16	33	24	-15
Total Gross Profit	193	203	204	232	257	263	260	304	331	347
Total Revenue	312	333	343	375	413	430	461	504	544	573
Operating Revenue	312	333	343	375	413	430	461	504	544	573
Total Cost of Revenue	118	130	139	142	157	167	201	200	214	227
Operating Cost of Revenue	118	130	139	142	157	167	201	200	214	227
Total Operating Expenses	161	181	187	192	199	220	244	271	307	362
Selling, General & Admin Expense	102	112	117	120	122	136	153	169	192	227
Research & Development Expense	59	69	71	72	77	84	91	101	114	135
Total Other Income / (Expense), net	-11	12	25	-52	14	13	149	18	55	100
Interest & Investment Income	-11	-87	9.67	9.66	10	12	10	9.78	11	5.46
Other Income / (Expense), net	-	-	16	-62	3.85	0.67	139	7.93	45	95
Income Tax Expense	8.73	5.48	-3.26	-25	10	-1.36	33	9.79	13	-50
Basic Earnings per Share	$0.17	$0.41	$0.62	$0.17	$0.82	$0.76	$1.77	$0.54	$0.89	$1.78
Weighted Average Basic Shares Outstanding	71.11M	71.09M	72.64M	74.22M	74.83M	74.20M	75.36M	75.51M	75.70M	75.75M
Diluted Earnings per Share	$0.17	$0.39	$0.61	$0.16	$0.81	$0.75	$1.73	$0.53	$0.86	$1.68
Weighted Average Diluted Shares Outstanding	72.53M	72.53M	73.88M	75.78M	75.95M	75.46M	77.13M	77.55M	78.08M	78.56M
Weighted Average Basic & Diluted Shares Outstanding	71.17M	72.86M	73.89M	74.76M	74.93M	75.30M	75.47M	75.57M	76.25M	76.62M

This table details how cash moves in and out of Axon Enterprise's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	11	-16	34	273	-179	-17	201	-0.89	245	-134
Net Cash From Operating Activities	46	21	18	64	66	38	124	235	189	408
Net Cash From Continuing Operating Activities	46	21	18	64	66	38	124	235	189	408
Net Income / (Loss) Continuing Operations	20	17	5.21	29	0.88	-1.72	-60	147	176	377
Consolidated Net Income / (Loss)	20	17	5.21	29	0.88	-1.72	-60	147	176	377
Depreciation Expense	3.29	3.66	8.04	11	11	12	19	23	19	48
Non-Cash Adjustments To Reconcile Net Income	0.38	9.10	17	25	86	142	285	24	191	141
Changes in Operating Assets and Liabilities, net	21	-10	-12	-1.42	-33	-117	-125	41	-197	-158
Net Cash From Investing Activities	-36	-3.05	19	-9.86	-241	-357	253	-831	12	-491
Net Cash From Continuing Investing Activities	-36	-3.05	19	-9.86	-241	-357	253	-831	12	-491
Purchase of Property, Plant & Equipment	-6.00	-4.96	-10	-11	-16	-73	-50	-56	-60	-79
Acquisitions	-12	-7.00	-12	-5.55	-0.40	-0.24	-23	-2.10	-21	-622
Purchase of Investments	-62	-56	-20	-4.33	-354	-664	-408	-845	-564	-793
Sale and/or Maturity of Investments	44	65	61	11	130	380	733	72	657	1,003
Other Investing Activities, net	-	-	-	0.00	-	-	-	-0.02	-0.54	0.05
Net Cash From Financing Activities	0.60	-35	-3.82	219	-3.94	299	-174	598	41	-45
Net Cash From Continuing Financing Activities	0.60	-35	-3.82	219	-3.94	299	-174	598	41	-45
Repayment of Debt	-0.08	-	-	-	-	-	-	0.00	0.00	-1.84
Issuance of Debt	-	-	-	-	-	0.00	0.00	674	0.00	0.00
Issuance of Common Equity	-	0.00	0.00	234	0.00	0.00	0.00	124	0.00	0.00
Other Financing Activities, net	8.24	-0.81	-3.82	-15	-3.94	299	-174	-200	41	-44
Effect of Exchange Rate Changes	0.12	0.91	-	-	0.33	1.98	-1.98	-3.38	2.07	-6.21
Cash Interest Paid	-	-	-	-	-	-	-	0.00	3.51	3.45
Cash Income Taxes Paid	-	-	-	-	-	-	-	11	64	68

This table details how cash moves in and out of Axon Enterprise's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	-65	206	-90	211	-68	193	-195	163	129	-231
Net Cash From Operating Activities	41	131	-56	43	63	140	-16	83	91	250
Net Cash From Continuing Operating Activities	41	131	-56	43	63	140	-16	83	91	250
Net Income / (Loss) Continuing Operations	12	29	45	12	61	57	133	41	68	135
Consolidated Net Income / (Loss)	12	29	45	12	61	57	133	41	68	135
Depreciation Expense	6.21	4.95	6.69	7.48	-1.33	6.47	12	13	6.18	18
Non-Cash Adjustments To Reconcile Net Income	43	31	22	98	32	40	-62	73	76	54
Changes in Operating Assets and Liabilities, net	-20	66	-127	-72	-35	37	-95	-41	-65	43
Net Cash From Investing Activities	-103	-529	-73	154	-122	53	-174	82	43	-442
Net Cash From Continuing Investing Activities	-103	-529	-73	154	-122	53	-174	82	43	-442
Purchase of Property, Plant & Equipment	-14	-12	-8.51	-13	-14	-24	-16	-11	-26	-25
Acquisitions	-0.09	0.19	-0.13	-21	0.12	-	-238	-0.03	-	-384
Purchase of Investments	-95	-574	-145	-112	-188	-119	-251	-240	-124	-178
Sale and/or Maturity of Investments	6.01	57	81	300	80	196	330	334	194	145
Other Investing Activities, net	-	-	-	-	-	-0.03	-	-	-	0.02
Net Cash From Financing Activities	-0.07	601	38	14	-7.12	-3.82	-2.71	-2.19	-7.71	-33
Net Cash From Continuing Financing Activities	-0.07	601	38	14	-7.12	-3.82	-2.71	-2.19	-7.71	-33
Other Financing Activities, net	-0.07	-197	38	14	-102	91	-2.71	-2.19	-7.71	-31

This table presents Axon Enterprise's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	230	278	338	720	846	1,381	1,688	2,852	3,409	4,475
Total Current Assets	161	177	205	558	609	982	1,109	1,805	2,394	2,297
Cash & Equivalents	60	41	75	349	172	155	356	354	599	455
Short-Term Investments	50	48	6.86	0.00	179	407	87	621	722	532
Note & Lease Receivable	28	39	56	131	147	229	321	358	413	548
Inventories, net	16	35	45	34	39	90	109	202	270	265
Prepaid Expenses	8.17	14	22	30	35	37	57	73	103	130
Other Current Assets	-	-	0.00	-	38	64	180	197	287	368
Plant, Property, & Equipment, net	22	24	31	38	44	105	138	170	201	247
Total Noncurrent Assets	47	77	102	123	192	294	440	877	815	1,930
Long-Term Investments	8.53	0.23	-	0.00	45	102	31	156	232	333
Noncurrent Note & Lease Receivables	1.23	18	37	40	32	22	11	5.21	2.59	3.46
Goodwill	9.60	10	15	25	25	25	44	45	58	757
Intangible Assets	7.59	15	19	16	13	9.45	15	12	20	175
Noncurrent Deferred & Refundable Income Taxes	14	20	16	19	28	46	127	157	228	304
Other Noncurrent Operating Assets	5.97	14	15	23	50	88	128	205	275	357
Total Liabilities & Shareholders' Equity	230	278	338	720	846	1,381	1,688	2,852	3,409	4,475
Total Liabilities	73	127	171	252	302	405	640	1,583	1,793	2,147
Total Current Liabilities	38	78	108	166	196	256	419	603	762	998
Accounts Payable	7.33	11	8.59	15	26	24	32	60	66	72
Accrued Expenses	8.64	18	24	41	45	60	104	156	194	279
Customer Deposits	1.23	2.15	-	-	-	2.96	10	20	22	21
Current Deferred Revenue	21	45	70	107	118	164	266	360	470	613
Other Current Liabilities	0.09	0.08	3.76	2.74	6.83	5.43	6.54	6.36	9.79	13
Total Noncurrent Liabilities	35	49	63	86	107	148	222	981	1,032	1,149
Long-Term Debt	-	-	-	-	-	-	-	674	677	680
Noncurrent Deferred Revenue	30	40	55	-	88	111	186	248	271	361
Noncurrent Deferred & Payable Income Tax Liabilities	1.32	1.90	1.71	2.85	4.19	5.15	4.61	11	18	25
Noncurrent Employee Benefit Liabilities	2.20	3.36	3.86	3.24	3.94	4.73	5.68	6.29	11	16
Other Noncurrent Operating Liabilities	1.03	3.92	2.27	80	11	27	26	42	54	67
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	157	151	167	467	543	976	1,048	1,268	1,616	2,328
Total Preferred & Common Equity	157	151	167	467	543	976	1,048	1,268	1,616	2,328
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	157	151	167	467	543	976	1,048	1,268	1,616	2,328
Common Stock	178	188	202	453	528	962	1,095	1,175	1,347	1,690
Retained Earnings	101	118	123	171	172	170	110	257	435	812
Treasury Stock	-122	-156	-156	-156	-156	-156	-156	-156	-156	-156
Accumulated Other Comprehensive Income / (Loss)	0.08	0.90	-1.47	-1.51	-1.10	0.14	-1.32	-7.18	-11	-18

This table presents Axon Enterprise's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Total Assets	2,010	2,852	3,008	3,077	3,254	3,409	3,616	3,742	4,006	4,475
Total Current Assets	1,206	1,805	2,053	2,113	2,258	2,394	2,202	2,206	2,434	2,297
Cash & Equivalents	148	354	263	474	406	599	404	566	695	455
Short-Term Investments	230	621	830	660	785	722	660	510	463	532
Note & Lease Receivable	418	358	380	372	443	413	477	386	513	548
Inventories, net	173	202	220	250	260	270	271	278	272	265
Prepaid Expenses	68	73	142	102	104	103	124	122	118	130
Other Current Assets	169	197	217	255	261	287	266	343	373	368
Plant, Property, & Equipment, net	164	170	173	179	187	201	209	215	236	247
Total Noncurrent Assets	641	877	783	786	809	815	1,205	1,321	1,336	1,930
Long-Term Investments	29	156	31	15	0.00	232	295	363	388	333
Noncurrent Note & Lease Receivables	8.46	5.21	4.47	5.28	4.38	2.59	2.40	3.04	2.90	3.46
Goodwill	45	45	45	58	57	58	308	308	308	757
Intangible Assets	13	12	11	22	20	20	89	86	82	175
Noncurrent Deferred & Refundable Income Taxes	96	157	171	199	214	228	209	227	244	304
Other Noncurrent Operating Assets	159	205	223	253	273	275	301	335	311	357
Total Liabilities & Shareholders' Equity	2,010	2,852	3,008	3,077	3,254	3,409	3,616	3,742	4,006	4,475
Total Liabilities	779	1,583	1,605	1,632	1,733	1,793	1,798	1,814	1,906	2,147
Total Current Liabilities	432	603	616	625	718	762	757	766	823	998
Accounts Payable	50	60	66	73	90	66	82	104	76	72
Accrued Expenses	113	156	121	118	147	194	127	142	210	279
Customer Deposits	15	20	14	15	16	22	22	23	22	21
Current Deferred Revenue	246	360	408	412	455	470	516	486	505	613
Other Current Liabilities	6.80	6.36	7.51	7.36	9.49	9.79	9.60	12	11	13
Total Noncurrent Liabilities	348	981	989	1,007	1,015	1,032	1,041	1,047	1,083	1,149
Long-Term Debt	-	674	675	676	676	677	678	679	679	680
Noncurrent Deferred Revenue	314	248	250	265	270	271	294	291	305	361
Noncurrent Deferred & Payable Income Tax Liabilities	7.32	11	16	21	21	18	19	19	20	25
Noncurrent Employee Benefit Liabilities	5.37	6.29	7.98	8.77	9.15	11	15	14	16	16
Other Noncurrent Operating Liabilities	21	42	40	37	38	54	36	44	62	67
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,231	1,268	1,403	1,445	1,521	1,616	1,818	1,929	2,100	2,328
Total Preferred & Common Equity	1,231	1,268	1,403	1,445	1,521	1,616	1,818	1,929	2,100	2,328
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00
Total Common Equity	1,231	1,268	1,403	1,445	1,521	1,616	1,818	1,929	2,100	2,328
Common Stock	1,167	1,175	1,262	1,293	1,316	1,347	1,421	1,494	1,588	1,690
Retained Earnings	228	257	302	315	374	435	564	605	677	812
Treasury Stock	-156	-156	-156	-156	-156	-156	-156	-156	-156	-156
Accumulated Other Comprehensive Income / (Loss)	-7.81	-7.18	-5.32	-6.73	-13	-11	-12	-14	-9.12	-18

This table displays calculated financial ratios and metrics derived from Axon Enterprise's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	20.28%	35.55%	28.17%	144.37%	-36.81%	28.28%	26.78%	37.50%	31.47%	33.44%
EBITDA Growth	6.61%	-8.70%	-42.72%	68.33%	-84.97%	-68.66%	-7,222.57%	280.80%	-37.57%	192.96%
EBIT Growth	8.71%	-9.86%	-59.11%	90.75%	-125.74%	-121.30%	-909.60%	234.36%	-40.11%	200.05%
NOPAT Growth	-0.60%	-12.18%	-75.40%	499.99%	-110.55%	-263.57%	-1,088.15%	159.15%	152.18%	-67.04%
Net Income Growth	0.08%	-13.22%	-69.90%	460.88%	-96.98%	-295.46%	-3,381.32%	344.81%	19.64%	114.49%
EPS Growth	-2.70%	-11.11%	-68.75%	400.00%	-98.00%	-400.00%	-2,933.33%	323.08%	14.78%	106.01%
Operating Cash Flow Growth	31.08%	-54.49%	-12.60%	245.81%	2.81%	-41.41%	223.52%	89.05%	-19.59%	115.74%
Free Cash Flow Firm Growth	-24.29%	-135.52%	828.21%	-247.41%	57.84%	-444.33%	-69.46%	115.11%	-212.03%	-1,678.79%
Invested Capital Growth	-0.10%	63.51%	-74.77%	638.11%	24.90%	111.87%	57.13%	5.08%	43.81%	128.06%
Revenue Q/Q Growth	4.89%	10.75%	3.80%	110.07%	-53.31%	28.33%	19.12%	10.81%	6.38%	7.26%
EBITDA Q/Q Growth	-0.66%	2.01%	-5.36%	-13.70%	-74.10%	107.52%	-6.00%	217.94%	-13.87%	10.35%
EBIT Q/Q Growth	-1.16%	2.92%	-11.94%	-18.54%	-164.04%	58.76%	-5.60%	339.77%	-15.99%	12.75%
NOPAT Q/Q Growth	-0.24%	7.34%	-61.09%	8.66%	-130.20%	58.76%	-24.28%	90.21%	18.06%	-40.04%
Net Income Q/Q Growth	0.10%	7.70%	-61.77%	16.58%	-94.25%	95.68%	-190.28%	40.66%	18.74%	27.20%
EPS Q/Q Growth	-2.70%	10.34%	-61.54%	11.11%	-95.65%	95.45%	-139.47%	32.68%	18.27%	24.68%
Operating Cash Flow Q/Q Growth	7.74%	-44.51%	376.72%	12.14%	28.51%	-22.99%	-14.66%	100.87%	4.95%	36.93%
Free Cash Flow Firm Q/Q Growth	5.15%	-135.79%	193.54%	-611.21%	-113.40%	-39.32%	-14.87%	165.97%	39.70%	-140.64%
Invested Capital Q/Q Growth	-14.19%	52.15%	-85.19%	-17.16%	-11.49%	16.54%	13.84%	-3.71%	-3.38%	36.97%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	65.01%	63.57%	60.24%	61.56%	57.88%	61.14%	62.65%	61.16%	61.22%	59.61%
EBITDA Margin	20.35%	13.71%	6.13%	4.22%	1.00%	0.25%	-13.78%	18.12%	8.60%	18.89%
Operating Margin	17.86%	11.87%	3.79%	2.96%	-1.20%	-2.08%	-19.47%	7.83%	10.05%	2.81%
EBIT Margin	17.86%	11.87%	3.79%	2.96%	-1.20%	-2.08%	-16.55%	16.17%	7.37%	16.56%
Profit (Net Income) Margin	10.07%	6.45%	1.51%	3.48%	0.17%	-0.25%	-6.95%	12.38%	11.26%	18.10%
Tax Burden Percent	56.37%	54.92%	33.04%	103.92%	42.61%	27.40%	42.45%	74.87%	111.92%	98.83%
Interest Burden Percent	100.07%	98.89%	121.02%	113.14%	-32.37%	44.46%	98.96%	102.24%	136.64%	110.61%
Effective Tax Rate	43.63%	45.08%	66.96%	-3.92%	57.39%	0.00%	0.00%	25.13%	-11.92%	1.17%
Return on Invested Capital (ROIC)	51.45%	34.30%	10.86%	38.58%	-2.06%	-4.31%	-29.35%	13.85%	27.96%	4.76%
ROIC Less NNEP Spread (ROIC-NNEP)	51.43%	34.49%	10.01%	37.15%	-3.02%	-5.86%	-38.79%	2.06%	27.93%	-37.41%
Return on Net Nonoperating Assets (RNNOA)	-37.51%	-23.07%	-7.31%	-28.99%	2.23%	4.09%	23.42%	-1.17%	-15.77%	14.36%
Return on Equity (ROE)	13.93%	11.24%	3.55%	9.58%	0.17%	-0.23%	-5.93%	12.69%	12.19%	19.12%
Cash Return on Invested Capital (CROIC)	51.54%	-13.90%	130.26%	-113.70%	-24.20%	-76.06%	-73.78%	8.89%	-7.98%	-73.31%
Operating Return on Assets (OROA)	17.02%	12.54%	5.82%	5.59%	-0.82%	-1.27%	-9.31%	8.46%	3.67%	8.75%
Return on Assets (ROA)	9.60%	6.81%	2.33%	6.57%	0.11%	-0.15%	-3.91%	6.47%	5.62%	9.56%
Return on Common Equity (ROCE)	13.93%	11.24%	3.55%	9.58%	0.17%	-0.23%	-5.93%	12.69%	12.19%	19.12%
Return on Equity Simple (ROE_SIMPLE)	12.70%	11.46%	3.66%	6.25%	0.16%	-0.18%	-5.73%	11.58%	10.88%	16.20%
Net Operating Profit after Tax (NOPAT)	20	17	4.30	26	-2.72	-9.91	-118	70	176	58
NOPAT Margin	10.07%	6.52%	1.25%	3.07%	-0.51%	-1.45%	-13.63%	5.86%	11.25%	2.78%
Net Nonoperating Expense Percent (NNEP)	0.01%	-0.19%	0.85%	1.43%	0.97%	1.54%	9.44%	11.79%	0.03%	42.17%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	3.58%	7.66%	1.92%
Cost of Revenue to Revenue	34.99%	36.57%	39.76%	38.44%	42.12%	38.87%	37.35%	38.84%	38.78%	40.39%
SG&A Expenses to Revenue	35.22%	40.29%	40.34%	18.67%	40.12%	45.12%	59.65%	33.64%	31.71%	35.59%
R&D to Revenue	11.93%	11.41%	16.11%	9.15%	18.97%	18.09%	22.47%	19.70%	19.46%	21.20%
Operating Expenses to Revenue	47.15%	51.70%	56.45%	-2.96%	59.09%	63.21%	82.12%	53.33%	51.17%	56.80%
Earnings before Interest and Taxes (EBIT)	35	32	13	25	-6.39	-14	-143	192	115	345
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	40	37	21	35	5.33	1.67	-119	215	134	393
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	5.91	8.40	9.86	5.47	8.00	7.98	10.26	9.31	11.65	18.60
Price to Tangible Book Value (P/TBV)	6.63	10.12	9.86	6.00	8.60	8.27	10.87	9.75	12.24	31.03
Price to Revenue (P/Rev)	4.69	4.72	4.08	3.04	8.19	11.43	12.45	9.95	12.06	20.79
Price to Earnings (P/E)	46.53	73.27	269.29	4.68	4,930.28	0.00	0.00	80.37	107.08	114.85
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	2.15%	1.36%	0.37%	21.37%	0.02%	0.00%	0.00%	1.24%	0.93%	0.87%
Enterprise Value to Invested Capital (EV/IC)	20.91	18.64	87.81	18.73	26.85	22.84	20.97	22.04	24.23	25.26
Enterprise Value to Revenue (EV/Rev)	4.09	4.40	4.08	2.63	7.44	10.46	11.90	9.56	11.50	20.49
Enterprise Value to EBITDA (EV/EBITDA)	20.09	32.08	66.57	62.26	741.78	4,264.92	0.00	52.78	133.67	108.47
Enterprise Value to EBIT (EV/EBIT)	22.90	37.04	107.67	88.87	0.00	0.00	0.00	59.14	156.13	123.70
Enterprise Value to NOPAT (EV/NOPAT)	40.62	67.44	325.91	85.52	0.00	0.00	0.00	163.07	102.24	737.46
Enterprise Value to Operating Cash Flow (EV/OCF)	17.42	55.82	75.91	34.56	60.18	185.09	82.54	48.23	94.83	104.49
Enterprise Value to Free Cash Flow (EV/FCFF)	40.55	0.00	27.17	0.00	0.00	0.00	0.00	253.99	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.53	0.42	0.29
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.53	0.42	0.29
Financial Leverage	-0.73	-0.67	-0.73	-0.78	-0.74	-0.70	-0.60	-0.57	-0.56	-0.38
Leverage Ratio	1.45	1.65	1.53	1.46	1.55	1.47	1.52	1.96	2.17	2.00
Compound Leverage Factor	1.45	1.63	1.85	1.65	-0.50	0.65	1.50	2.00	2.97	2.21
Debt to Total Capital	0.00%	1.11%	0.00%	0.00%	0.00%	0.00%	0.00%	34.70%	29.53%	22.62%
Short-Term Debt to Total Capital	0.00%	1.11%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	34.70%	29.53%	22.62%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	98.89%	100.00%	100.00%	100.00%	100.00%	100.00%	65.30%	70.47%	77.38%
Debt to EBITDA	0.00	0.05	0.00	0.00	0.00	0.00	0.00	3.13	5.04	1.73
Net Debt to EBITDA	0.00	-2.38	0.00	0.00	0.00	0.00	0.00	-2.12	-6.52	-1.62
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.13	5.04	1.73
Debt to NOPAT	0.00	0.10	0.00	0.00	0.00	0.00	0.00	9.68	3.86	11.76
Net Debt to NOPAT	0.00	-5.01	0.00	0.00	0.00	0.00	0.00	-6.56	-4.99	-11.04
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	9.68	3.86	11.76
Altman Z-Score	10.26	8.34	9.06	8.35	10.11	12.80	10.89	5.75	7.62	13.42
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	4.23	2.27	1.17	3.36	3.12	3.83	2.65	3.00	3.14	2.30
Quick Ratio	3.60	1.65	0.87	2.98	2.54	3.09	1.83	2.21	2.28	1.54
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	20	-7.09	52	-76	-32	-175	-296	45	-50	-891
Operating Cash Flow to CapEx	778.89%	430.01%	177.69%	573.44%	412.03%	53.05%	249.77%	421.78%	317.37%	518.26%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.95	1.06	1.54	1.89	0.68	0.61	0.56	0.52	0.50	0.53
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	4.06	3.88	0.00	0.00	6.16	4.11	3.25	2.96	2.56	3.14
Fixed Asset Turnover	10.05	11.70	0.00	0.00	13.00	9.12	7.08	7.70	8.43	9.30
Accounts Payable Turnover	9.22	10.86	0.00	0.00	10.90	10.58	11.44	10.01	9.62	12.21
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	89.84	94.13	0.00	0.00	59.27	88.81	112.42	123.17	142.42	116.11
Days Payable Outstanding (DPO)	39.57	33.61	0.00	0.00	33.50	34.49	31.90	36.47	37.92	29.90
Cash Conversion Cycle (CCC)	50.26	60.52	0.00	0.00	25.77	54.33	80.52	86.70	104.50	86.21
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	39	63	16	118	147	312	490	515	741	1,689
Invested Capital Turnover	5.11	5.26	8.68	12.56	4.01	2.97	2.15	2.36	2.49	1.71
Increase / (Decrease) in Invested Capital	-0.04	25	-47	102	29	165	178	25	226	948
Enterprise Value (EV)	809	1,180	1,402	2,208	3,952	7,122	10,275	11,352	17,947	42,665
Market Capitalization	927	1,267	1,402	2,557	4,349	7,787	10,749	11,808	18,822	43,303
Book Value per Share	$2.93	$2.89	$2.69	$8.00	$9.16	$15.36	$15.30	$17.82	$21.56	$30.52
Tangible Book Value per Share	$2.61	$2.40	$2.69	$7.30	$8.52	$14.82	$14.44	$17.02	$20.53	$18.30
Total Capital	157	153	142	467	543	976	1,048	1,942	2,293	3,008
Total Debt	0.00	1.69	0.00	0.00	0.00	0.00	0.00	674	677	680
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	674	677	680
Net Debt	-118	-88	0.00	-349	-396	-664	-474	-457	-875	-639
Capital Expenditures (CapEx)	5.96	4.92	10	11	16	73	50	56	60	79
Debt-free, Cash-free Net Working Capital (DFCFNWC)	13	12	17	43	63	164	248	228	312	314
Debt-free Net Working Capital (DFNWC)	123	101	17	392	414	726	691	1,203	1,632	1,300
Net Working Capital (NWC)	123	99	17	392	414	726	691	1,203	1,632	1,300
Net Nonoperating Expense (NNE)	-0.01	0.19	-0.90	-3.39	-3.61	-8.18	-58	-77	-0.24	-319
Net Nonoperating Obligations (NNO)	-118	-88	-126	-349	-396	-664	-558	-753	-875	-639
Total Depreciation and Amortization (D&A)	4.94	4.92	8.04	11	12	16	24	23	19	48
Debt-free, Cash-free Net Working Capital to Revenue	6.82%	4.40%	4.92%	5.08%	11.89%	24.03%	28.72%	19.20%	19.96%	15.06%
Debt-free Net Working Capital to Revenue	62.29%	37.61%	4.92%	46.68%	77.97%	106.55%	80.03%	101.30%	104.58%	62.42%
Net Working Capital to Revenue	62.29%	36.98%	4.92%	46.68%	77.97%	106.55%	80.03%	101.30%	104.58%	62.42%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.37	$0.33	$0.10	$0.52	$0.01	($0.03)	($0.91)	$2.07	$2.35	$4.98
Adjusted Weighted Average Basic Shares Outstanding	53.55M	52.67M	52.73M	56.39M	59.19M	61.78M	66.19M	71.09M	74.20M	75.75M
Adjusted Diluted Earnings per Share	$0.36	$0.32	$0.10	$0.50	$0.01	($0.03)	($0.91)	$2.03	$2.31	$4.80
Adjusted Weighted Average Diluted Shares Outstanding	54.64M	53.54M	53.90M	57.92M	60.02M	61.78M	66.19M	72.53M	75.46M	78.56M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	53.69M	52.33M	53.03M	58.83M	59.53M	63.78M	70.93M	72.86M	75.30M	76.62M
Normalized Net Operating Profit after Tax (NOPAT)	20	17	9.12	17	-4.48	-9.91	-118	70	110	58
Normalized NOPAT Margin	10.07%	6.52%	2.65%	2.07%	-0.84%	-1.45%	-13.63%	5.86%	7.04%	2.78%
Pre Tax Income Margin	17.87%	11.74%	4.58%	3.35%	0.39%	-0.92%	-16.37%	16.53%	10.06%	18.32%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	37.91%	195.10%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Axon Enterprise's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	34.38%	53.21%	33.78%	31.16%	32.57%	28.93%	34.31%	34.57%	31.70%	33.42%
EBITDA Growth	311.44%	228.45%	54.81%	-163.62%	57.96%	82.69%	354.82%	389.84%	24.73%	96.86%
EBIT Growth	1,010.97%	182.25%	87.38%	-201.69%	90.83%	94.21%	382.17%	287.43%	11.95%	85.43%
NOPAT Growth	823.06%	198.79%	37.53%	76.75%	162.82%	132.96%	-26.88%	-5.93%	-58.67%	-153.53%
Net Income Growth	-75.00%	314.44%	-17.74%	-75.63%	405.39%	96.49%	195.13%	228.48%	9.32%	138.94%
EPS Growth	-74.63%	454.55%	-19.74%	-77.46%	376.47%	92.31%	183.61%	231.25%	6.17%	124.00%
Operating Cash Flow Growth	148.65%	914.08%	-228.11%	120.15%	53.77%	6.80%	71.70%	94.02%	45.20%	78.64%
Free Cash Flow Firm Growth	46.73%	96.85%	-8.17%	-25.75%	-113.18%	-2,834.38%	-210.88%	-102.52%	-144.35%	-433.92%
Invested Capital Growth	24.24%	5.08%	34.40%	44.65%	43.33%	43.81%	73.09%	58.37%	60.87%	128.06%
Revenue Q/Q Growth	9.15%	6.93%	2.05%	9.20%	10.32%	3.99%	6.62%	9.41%	7.97%	5.35%
EBITDA Q/Q Growth	36.70%	-28.31%	29.86%	-149.38%	439.39%	-17.09%	230.16%	-68.54%	46.06%	30.86%
EBIT Q/Q Growth	49.96%	-30.67%	42.93%	-167.58%	381.42%	-29.44%	262.88%	-73.73%	68.08%	16.87%
NOPAT Q/Q Growth	17.12%	0.24%	-5.48%	57.45%	74.15%	-11.15%	-70.21%	102.57%	-23.48%	-215.06%
Net Income Q/Q Growth	-76.20%	138.78%	54.72%	-72.49%	393.63%	-7.17%	132.61%	-69.38%	64.29%	102.90%
EPS Q/Q Growth	-76.06%	129.41%	56.41%	-73.77%	406.25%	-7.41%	127.63%	-69.36%	62.26%	95.35%
Operating Cash Flow Q/Q Growth	111.09%	220.58%	-142.96%	175.73%	47.44%	122.66%	-111.38%	619.28%	10.34%	173.94%
Free Cash Flow Firm Q/Q Growth	45.99%	92.76%	-2,409.42%	-32.82%	8.43%	0.35%	-162.36%	13.48%	-10.48%	-117.74%
Invested Capital Q/Q Growth	4.91%	-3.71%	27.51%	12.30%	3.95%	-3.38%	54.25%	2.75%	5.59%	36.97%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	61.99%	60.94%	59.50%	61.96%	62.10%	61.10%	56.44%	60.25%	60.77%	60.49%
EBITDA Margin	12.17%	8.16%	10.43%	-4.72%	14.51%	11.56%	35.31%	10.16%	13.74%	17.06%
Operating Margin	10.30%	6.68%	4.84%	10.75%	13.89%	9.90%	3.53%	6.52%	4.42%	-2.56%
EBIT Margin	10.30%	6.68%	9.39%	-5.81%	14.83%	10.06%	33.72%	8.10%	12.60%	13.98%
Profit (Net Income) Margin	3.89%	8.69%	13.16%	3.32%	14.83%	13.24%	28.91%	8.09%	12.31%	23.72%
Tax Burden Percent	58.16%	84.08%	107.77%	-102.57%	85.47%	102.44%	80.39%	80.64%	84.24%	158.83%
Interest Burden Percent	64.96%	154.76%	130.00%	55.62%	117.07%	128.51%	106.68%	123.97%	116.01%	106.81%
Effective Tax Rate	41.84%	15.92%	-7.77%	0.00%	14.53%	-2.44%	19.61%	19.36%	15.76%	-58.83%
Return on Invested Capital (ROIC)	13.30%	13.26%	11.63%	16.47%	26.77%	25.22%	5.33%	9.99%	7.24%	-6.98%
ROIC Less NNEP Spread (ROIC-NNEP)	14.24%	11.70%	7.69%	18.74%	25.09%	23.59%	-11.50%	8.05%	1.47%	-28.03%
Return on Net Nonoperating Assets (RNNOA)	-8.38%	-6.62%	-4.21%	-9.88%	-13.23%	-13.32%	5.10%	-3.50%	-0.66%	10.76%
Return on Equity (ROE)	4.91%	6.64%	7.43%	6.59%	13.55%	11.90%	10.42%	6.49%	6.58%	3.78%
Cash Return on Invested Capital (CROIC)	-14.04%	8.89%	-15.95%	-15.79%	-12.76%	-7.98%	-37.32%	-32.04%	-37.02%	-73.31%
Operating Return on Assets (OROA)	6.04%	3.49%	5.02%	-3.17%	8.26%	5.02%	17.11%	4.30%	6.74%	7.39%
Return on Assets (ROA)	2.28%	4.54%	7.03%	1.81%	8.27%	6.60%	14.68%	4.30%	6.59%	12.53%
Return on Common Equity (ROCE)	4.91%	6.64%	7.43%	6.59%	13.55%	11.90%	10.42%	6.49%	6.58%	3.78%
Return on Equity Simple (ROE_SIMPLE)	8.48%	0.00%	9.79%	6.84%	9.73%	0.00%	14.43%	15.07%	14.12%	0.00%
Net Operating Profit after Tax (NOPAT)	19	19	18	28	49	44	13	27	20	-23
NOPAT Margin	5.99%	5.61%	5.22%	7.52%	11.88%	10.15%	2.84%	5.26%	3.73%	-4.07%
Net Nonoperating Expense Percent (NNEP)	-0.95%	1.56%	3.94%	-2.27%	1.69%	1.63%	16.83%	1.95%	5.77%	21.05%
Return On Investment Capital (ROIC_SIMPLE)	-	0.96%	-	-	-	1.90%	-	-	-	-0.78%
Cost of Revenue to Revenue	38.01%	39.06%	40.50%	38.04%	37.90%	38.90%	43.56%	39.75%	39.23%	39.51%
SG&A Expenses to Revenue	32.73%	33.65%	33.98%	32.01%	29.61%	31.65%	33.14%	33.61%	35.31%	39.58%
R&D to Revenue	18.97%	20.62%	20.68%	19.20%	18.60%	19.54%	19.77%	20.12%	21.03%	23.47%
Operating Expenses to Revenue	51.69%	54.27%	54.66%	51.22%	48.21%	51.19%	52.91%	53.73%	56.34%	63.05%
Earnings before Interest and Taxes (EBIT)	32	22	32	-22	61	43	155	41	69	80
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	38	27	36	-18	60	50	163	51	75	98
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	6.68	9.31	11.68	9.84	9.53	11.65	12.54	11.12	13.87	18.60
Price to Tangible Book Value (P/TBV)	7.01	9.75	12.17	10.41	10.04	12.24	16.05	13.96	17.03	31.03
Price to Revenue (P/Rev)	7.68	9.95	12.83	10.41	9.88	12.06	13.56	11.84	15.00	20.79
Price to Earnings (P/E)	78.76	80.37	119.23	143.80	97.94	107.08	86.91	73.75	98.23	114.85
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	1.27%	1.24%	0.84%	0.70%	1.02%	0.93%	1.15%	1.36%	1.02%	0.87%
Enterprise Value to Invested Capital (EV/IC)	14.62	22.04	24.26	18.64	18.24	24.23	19.46	17.71	22.91	25.26
Enterprise Value to Revenue (EV/Rev)	7.30	9.56	12.48	10.06	9.53	11.50	13.16	11.42	14.55	20.49
Enterprise Value to EBITDA (EV/EBITDA)	115.63	52.78	140.48	105.69	89.71	133.67	85.35	63.05	79.25	108.47
Enterprise Value to EBIT (EV/EBIT)	179.19	59.14	171.94	123.24	102.21	156.13	93.70	69.25	92.34	123.70
Enterprise Value to NOPAT (EV/NOPAT)	213.71	163.07	207.61	106.41	94.05	102.24	152.20	165.19	292.76	737.46
Enterprise Value to Operating Cash Flow (EV/OCF)	66.75	48.23	117.96	86.79	77.54	94.83	96.30	76.65	94.74	104.49
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	253.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.53	0.48	0.47	0.44	0.42	0.37	0.35	0.32	0.29
Long-Term Debt to Equity	0.00	0.53	0.48	0.47	0.44	0.42	0.37	0.35	0.32	0.29
Financial Leverage	-0.59	-0.57	-0.55	-0.53	-0.53	-0.56	-0.44	-0.44	-0.45	-0.38
Leverage Ratio	1.56	1.96	1.89	1.90	1.91	2.17	2.06	2.02	2.01	2.00
Compound Leverage Factor	1.01	3.03	2.46	1.06	2.24	2.79	2.19	2.51	2.33	2.14
Debt to Total Capital	0.00%	34.70%	32.47%	31.86%	30.78%	29.53%	27.16%	26.03%	24.45%	22.62%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	34.70%	32.47%	31.86%	30.78%	29.53%	27.16%	26.03%	24.45%	22.62%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	65.30%	67.53%	68.14%	69.22%	70.47%	72.84%	73.97%	75.55%	77.38%
Debt to EBITDA	0.00	3.13	5.95	5.20	4.34	5.04	2.62	2.07	1.91	1.73
Net Debt to EBITDA	0.00	-2.12	-3.97	-3.64	-3.30	-6.52	-2.63	-2.32	-2.43	-1.62
Long-Term Debt to EBITDA	0.00	3.13	5.95	5.20	4.34	5.04	2.62	2.07	1.91	1.73
Debt to NOPAT	0.00	9.68	8.79	5.23	4.55	3.86	4.67	5.42	7.04	11.76
Net Debt to NOPAT	0.00	-6.56	-5.86	-3.67	-3.46	-4.99	-4.69	-6.08	-8.98	-11.04
Long-Term Debt to NOPAT	0.00	9.68	8.79	5.23	4.55	3.86	4.67	5.42	7.04	11.76
Altman Z-Score	7.54	5.55	7.30	6.37	6.26	7.55	8.91	8.30	10.43	13.23
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.79	3.00	3.33	3.38	3.15	3.14	2.91	2.88	2.96	2.30
Quick Ratio	1.84	2.21	2.39	2.41	2.28	2.28	2.03	1.91	2.03	1.54
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-86	-6.20	-150	-199	-183	-182	-467	-404	-446	-972
Operating Cash Flow to CapEx	287.31%	1,131.91%	-661.61%	324.78%	450.06%	583.22%	-98.63%	731.25%	344.97%	1,008.69%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.59	0.52	0.53	0.55	0.56	0.50	0.51	0.53	0.53	0.53
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	3.10	2.96	2.92	2.63	2.62	2.56	2.72	2.76	2.95	3.14
Fixed Asset Turnover	7.31	7.70	7.92	8.10	8.36	8.43	8.81	9.18	9.18	9.30
Accounts Payable Turnover	10.65	10.01	8.66	7.94	8.11	9.62	9.05	8.22	9.47	12.21
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	117.59	123.17	125.09	139.03	139.05	142.42	133.95	132.31	123.85	116.11
Days Payable Outstanding (DPO)	34.27	36.47	42.14	46.00	45.02	37.92	40.35	44.41	38.53	29.90
Cash Conversion Cycle (CCC)	83.32	86.70	82.96	93.04	94.04	104.50	93.61	87.90	85.32	86.21
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	535	515	657	737	767	741	1,137	1,168	1,233	1,689
Invested Capital Turnover	2.22	2.36	2.23	2.19	2.25	2.49	1.87	1.90	1.94	1.71
Increase / (Decrease) in Invested Capital	104	25	168	228	232	226	480	430	467	948
Enterprise Value (EV)	7,821	11,352	15,933	13,743	13,985	17,947	22,116	20,678	28,249	42,665
Market Capitalization	8,227	11,808	16,383	14,217	14,499	18,822	22,797	21,439	29,116	43,303
Book Value per Share	$17.32	$17.82	$19.26	$19.56	$20.35	$21.56	$24.13	$25.56	$27.79	$30.52
Tangible Book Value per Share	$16.51	$17.02	$18.48	$18.48	$19.31	$20.53	$18.85	$20.35	$22.62	$18.30
Total Capital	1,231	1,942	2,078	2,121	2,197	2,293	2,496	2,608	2,779	3,008
Total Debt	0.00	674	675	676	676	677	678	679	679	680
Total Long-Term Debt	0.00	674	675	676	676	677	678	679	679	680
Net Debt	-406	-457	-450	-474	-514	-875	-681	-761	-867	-639
Capital Expenditures (CapEx)	14	12	8.51	13	14	24	16	11	26	25
Debt-free, Cash-free Net Working Capital (DFCFNWC)	397	228	343	353	349	312	380	363	452	314
Debt-free Net Working Capital (DFNWC)	774	1,203	1,437	1,487	1,540	1,632	1,444	1,440	1,611	1,300
Net Working Capital (NWC)	774	1,203	1,437	1,487	1,540	1,632	1,444	1,440	1,611	1,300
Net Nonoperating Expense (NNE)	6.54	-10	-27	16	-12	-13	-120	-14	-47	-159
Net Nonoperating Obligations (NNO)	-696	-753	-746	-708	-755	-875	-681	-761	-867	-639
Total Depreciation and Amortization (D&A)	5.84	4.95	3.56	4.11	-1.33	6.47	7.36	10	6.18	18
Debt-free, Cash-free Net Working Capital to Revenue	37.01%	19.20%	26.89%	25.88%	23.82%	19.96%	22.63%	20.06%	23.29%	15.06%
Debt-free Net Working Capital to Revenue	72.26%	101.30%	112.54%	108.92%	104.97%	104.58%	85.91%	79.51%	82.95%	62.42%
Net Working Capital to Revenue	72.26%	101.30%	112.54%	108.92%	104.97%	104.58%	85.91%	79.51%	82.95%	62.42%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.17	$0.41	$0.62	$0.17	$0.79	$0.76	$1.77	$0.54	$0.89	$1.78
Adjusted Weighted Average Basic Shares Outstanding	71.11M	71.09M	72.64M	74.22M	74.83M	74.20M	75.36M	75.51M	75.70M	75.75M
Adjusted Diluted Earnings per Share	$0.17	$0.39	$0.61	$0.16	$0.78	$0.75	$1.73	$0.53	$0.86	$1.68
Adjusted Weighted Average Diluted Shares Outstanding	72.53M	72.53M	73.88M	75.78M	75.95M	75.46M	77.13M	77.55M	78.08M	78.56M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	71.17M	72.86M	73.89M	74.76M	74.93M	75.30M	75.47M	75.57M	76.25M	76.62M
Normalized Net Operating Profit after Tax (NOPAT)	19	19	12	28	49	30	13	27	20	-10
Normalized NOPAT Margin	5.99%	5.61%	3.39%	7.52%	11.88%	6.93%	2.84%	5.26%	3.73%	-1.79%
Pre Tax Income Margin	6.69%	10.33%	12.21%	-3.23%	17.36%	12.93%	35.97%	10.04%	14.62%	14.93%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Axon Enterprise's Financials

When does Axon Enterprise's financial year end?

According to the most recent income statement we have on file, Axon Enterprise's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Axon Enterprise's net income changed over the last 9 years?

Axon Enterprise's net income appears to be on an upward trend, with a most recent value of $377.03 million in 2024, rising from $19.93 million in 2015. The previous period was $175.78 million in 2023.

What is Axon Enterprise's operating income?

Axon Enterprise's total operating income in 2024 was $58.54 million, based on the following breakdown:

Total Gross Profit: $1.24 billion
Total Operating Expenses: $1.18 billion

How has Axon Enterprise revenue changed over the last 9 years?

Over the last 9 years, Axon Enterprise's total revenue changed from $197.89 million in 2015 to $2.08 billion in 2024, a change of 952.4%.

How much debt does Axon Enterprise have?

Axon Enterprise's total liabilities were at $2.15 billion at the end of 2024, a 19.7% increase from 2023, and a 2,846.0% increase since 2015.

How much cash does Axon Enterprise have?

In the past 9 years, Axon Enterprise's cash and equivalents has ranged from $40.65 million in 2016 to $598.55 million in 2023, and is currently $454.84 million as of their latest financial filing in 2024.

How has Axon Enterprise's book value per share changed over the last 9 years?

Over the last 9 years, Axon Enterprise's book value per share changed from 2.93 in 2015 to 30.52 in 2024, a change of 942.9%.

This page (LON:AXON) was last updated on 5/3/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Axon Enterprise (AXON) Financials

Frequently Asked Questions About Axon Enterprise's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Axon Enterprise (AXON) Financials

Annual Income Statements for Axon Enterprise

Quarterly Income Statements for Axon Enterprise

Annual Cash Flow Statements for Axon Enterprise

Quarterly Cash Flow Statements for Axon Enterprise

Annual Balance Sheets for Axon Enterprise

Quarterly Balance Sheets for Axon Enterprise

Annual Metrics and Ratios for Axon Enterprise

Quarterly Metrics and Ratios for Axon Enterprise

Frequently Asked Questions About Axon Enterprise's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools